Summary
Astellas Pharma Inc. filed an extraordinary report via EDINET on 2025-02-04 15:40 JST. Reason(s) cited: extraordinary report.
Stock price4503 · View chart ↗
Open the price chart on TradingView.
Source: EDINET S100V6B3 ↗ · PDL1.0 · Not investment advice